From Yahoo Finance: 2025-04-14 14:03:00

Ascendis Pharma A/S (ASND) is under the spotlight as one of the best growth stocks to buy according to billionaires. The stock market has been volatile, with a 19% decrease in the S&P 500, causing concern for a possible recession. Fundstrat’s Tom Lee believes there’s a window for stocks to rebound if tariff tensions de-escalate. With 260.25% sales growth in three years, ASND ranks 10th in billionaire-approved growth stocks. Bank of America Securities analyst Tazeen Ahmad maintains a Buy rating on ASND, citing strong demand for Yorvipath. The drug has shown promising early launch results, with 908 prescriptions reported in the fiscal fourth quarter of 2024. ASND is projected to launch in additional European markets, making it an attractive growth stock option.



Read more at Yahoo Finance: Is Ascendis Pharma A/S (ASND) the Best Growth Stock to Buy According to Billionaires?